IXICO's AGM Results 2015

March 6, 2015
News Download PDF

IXICO plc (Ticker: IXI) (“IXICO” or the “Company”), the brain health company, announces that all resolutions put to its Annual General Meeting held earlier today were duly passed.

About IXICO

IXICO, the brain health company, uses its innovative and proprietary digital platform technologies to help those involved in researching and treating serious diseases to make rapid decisions and improve patient outcomes.  Established since 2004, IXICO has significant experience in working with global pharmaceutical and biotechnology companies in dementia clinical studies and other neuro-degenerative disorders including Huntington’s disease and Multiple Sclerosis.

More information is available on www.ixico.com

 

Enquiries:

 

IXICO plc 

Derek Hill, CEO

Susan Lowther, CFO

Charles Spicer, VP Corporate Development

+44 20 3763 7499

 

Peel Hunt LLP (Nominated Adviser and Broker)

James Steel

Clare Terlouw

+44 20 7418 8900

 

Daniel Stewart & Company (Joint Broker)

Martin Lampshire

Mark Treharne

+44 207 776 6550

 

FTI Consulting Limited (Investor Relations)

Ben Atwell

Simon Conway

Matthew Moss

+44 20 3727 1000